Khaled A M Abouzid

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Molecular Docking

Anti Inflammatory

Top Venues

RSC medicinal chemistry

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Maiy Y Jaballah, Nooran S Elleboudy, Marwa Sharaky, Khaled A M Abouzid, Mai I Shahin
Design, synthesis and biological evaluation of novel pyrazole-based compounds as potential chemotherapeutic agents. Future medicinal chemistry 16 (13) (2024)
Norhan A Abdelrahman, Ahmed Ali Al-Karmalawy, Maiy Y Jaballah, Galal Yahya, Marwa Sharaky, Khaled A M Abouzid
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy. RSC medicinal chemistry 15 (3) (2024)
Norhan A Abdelrahman, Ahmed Ali Al-Karmalawy, Maiy Y Jaballah, Galal Yahya, Marwa Sharaky, Khaled A M Abouzid
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy. RSC medicinal chemistry 15 (3) (2024)
Maiy Y Jaballah, Nooran S Elleboudy, Marwa Sharaky, Khaled A M Abouzid, Mai I Shahin
Design, synthesis and biological evaluation of novel pyrazole-based compounds as potential chemotherapeutic agents. Future medicinal chemistry 16 (13) (2024)
Mohamed K S El-Nagar, Mai I Shahin, Mohammed F El-Behairy, Ehab S Taher, Mohamed F El-Badawy, Marwa Sharaky, Dalal A Abou El Ella, Khaled A M Abouzid, Mai Adel
Pyridazinone-based derivatives as anticancer agents endowed with anti-microbial activity: molecular design, synthesis, and biological investigation. RSC medicinal chemistry (2024)
Maiy Y Jaballah, Nooran S Elleboudy, Marwa Sharaky, Khaled A M Abouzid, Mai I Shahin
Design, synthesis and biological evaluation of novel pyrazole-based compounds as potential chemotherapeutic agents. Future medicinal chemistry 16 (13) (2024)
Rania M Shaban, Nermin Samir, Yassin M Nissan, Khaled A M Abouzid
Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4- d ]pyrimidine derivatives as anti-cancer agents. RSC advances 13 (25) (2023)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Tamer Nasr, Ahmed M Aboshanab, George Mpekoulis, Antonios Drakopoulos, Niki Vassilaki, Grigoris Zoidis, Khaled A M Abouzid, Wafaa Zaghary
Novel 6-Aminoquinazolinone Derivatives as Potential Cross GT1-4 HCV NS5B Inhibitors. Viruses 14 (12) (2022)
Natasha Rana, Marwa A Aziz, Ahmed K Oraby, Melinda Wuest, Jennifer Dufour, Khaled A M Abouzid, Frank Wuest, Frederick G West
Towards Selective Binding to the GLUT5 Transporter: Synthesis, Molecular Dynamics and In Vitro Evaluation of Novel C-3-Modified 2,5-Anhydro-D-mannitol Analogs. Pharmaceutics 14 (4) (2022)
Abeer H A Abdelhafiz, Rabah A T Serya, Deena S Lasheen, Nessa Wang, Mansour Sobeh, Michael Wink, Khaled A M Abouzid
Molecular design, synthesis and biological evaluation of novel 1,2,5-trisubstituted benzimidazole derivatives as cytotoxic agents endowed with ABCB1 inhibitory action to overcome multidrug resistance in cancer cells. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Mai A Mansour, Mamdouh A Oraby, Zeinab A Muhammad, Deena S Lasheen, Hatem M Gaber, Khaled A M Abouzid
Identification of novel furo[2,3- d ]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation. RSC advances 12 (13) (2022)
Hend Mohamed Abdel-Bar, Inas A Abdallah, Marwa A A Fayed, Yassmin Moatasim, Ahmed Mostafa, Mohammed Farrag El-Behairy, Hanan Elimam, Yaseen A M M Elshaier, Khaled A M Abouzid
Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies. RSC advances 11 (46) (2021)
Sayed K Ramadan, Eman Z Elrazaz, Khaled A M Abouzid, Abeer M El-Naggar
Design, synthesis and in silico studies of new quinazolinone derivatives as antitumor PARP-1 inhibitors. RSC advances 10 (49) (2020)
Mai A Mansour, Deena S Lasheen, Hatem M Gaber, Khaled A M Abouzid
Elaborating piperazinyl-furopyrimidine based scaffolds as phosphoinositol-3-kinase enzyme alpha (PI3Kα) inhibitors to combat pancreatic cancer. RSC advances 10 (53) (2020)
Aliya M S El Newahie, Yassin M Nissan, Nasser S M Ismail, Dalal A Abou El Ella, Sohair M Khojah, Khaled A M Abouzid
Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers. Molecules (Basel, Switzerland) 24 (6) (2019)